BMY icon

Bristol-Myers Squibb

2,525 hedge funds and large institutions have $126B invested in Bristol-Myers Squibb in 2022 Q2 according to their latest regulatory filings, with 152 funds opening new positions, 961 increasing their positions, 1,061 reducing their positions, and 96 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

1% more funds holding

Funds holding: 2,5042,525 (+21)

0.48% more ownership

Funds ownership: 76.72%77.19% (+0.48%)

9% less repeat investments, than reductions

Existing positions increased: 961 | Existing positions reduced: 1,061

Holders
2,525
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
132
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.58B
Puts
$1.98B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$15.2B
2
$13.1B
3
$7.53B
4
$7.2B
5
$5.53B
6
$3.59B
7
$2.93B
8
$2.92B
9
$2.79B
10
$2.75B
11
$1.93B
12
$1.89B
13
$1.71B
14
$1.56B
15
$1.48B
16
$1.41B
17
$1.39B
18
$1.35B
19
$1.31B
20
$1.21B
21
$1.12B
22
$1.12B
23
$1.11B
24
$1B
25
$954M